Type of Cancer
Phase
Division (Location)
Study ID
NCT#
Brief Description
A phase 1, multicenter, open-label, dose-escalation study of SGN 2FF in patients with advanced solid tumors
To find out more about this clinical trial, or to schedule an appointment, call (201) 518-3587.